From Race for the First, To Race against the Variants
In early 2020, several companies have worked round-the-clock to commercialize the first COVID-19 vaccine. Pfizer/BioNTech, Sinovac, ...
The Health Quarters: Esco Healthcare Quarterly Newsletter (Issue 1, May 2021)
Esco Healthcare unveils the first issue of its quarterly newsletter, The Health Quarters (The HQ), featuring its esteemed project h...
Adherent & Suspension Cell Culture in Bioprocessing
Growing adherent cells in culture involves a treated surface for attachment (in monolayers or in vivo) while suspension cells are free-float...
Where We are Now in the Race for the COVID-19 Vaccine
The COVID-19 pandemic is an uncharted territory where almost all countries of the world have established the use of mouth-and-nose protectio...
The Race for the SARS-CoV-2 Vaccine
Health authorities around the world are on high alert due to an outbreak of respiratory illness caused by a novel coronavirus that was first...
Coronaviruses: Lessons from Past Outbreaks to Aid in the Development of Tools against COVID-19
Officially named by the World Health Organization as COVID-19, the recent coronavirus disease outbreak that started in Wuhan, China remains ...
Viral in 2020: Tide Motion Platform for Viral Vector Manufacturing
Viral vectors are derived from parental wild-type viruses, whose pathogenic genes are removed and replaced with gene...
Why the TideXcell™ Cell Harvesting System Is a 20/20
Cell attachment in 3-dimensional carriers is proven advantageous for adherent cell growth to mimic the in vivo